贝恩医疗：每天6万套血路管发往海外

对于全球数百万终末期肾病患者而言至关重要的血路管，由贝恩医疗设备（湖南）有限公司大量生产。这几天，公司正在赶阿根廷、巴西、瑞士、越南等国家的订单。

Blood tubing, which is crucial for millions of end-stage renal disease patients worldwide, is mass-produced by Bain Medical Equipment (Hunan) Co., Ltd. These days, the company is rushing to fulfill orders from countries such as Argentina, Brazil, Switzerland, and Vietnam.

贝恩医疗位于中国浏阳市，其生产车间的生产线昼夜运转，每天制造18万套血路管，其中6万套销往海外，产品订单爆满、供不应求。作为国家高新技术企业，公司坚持自主创新，自研先进的全自动化生产线，产品科技含量高，在血路管生产领域成绩斐然。

Located in Liuyang City, China, the production lines in Bain Medical's workshops operate around the clock. They manufacture 180,000 sets of blood tubing every day, with 60,000 sets being sold overseas. The products are so popular that there are overwhelming orders and the supply cannot meet the demand. As a national high-tech enterprise, the company adheres to independent innovation and has developed advanced fully-automated production lines on its own. Its products are highly technological and have achieved remarkable results in the field of blood tubing production.

作为湘商回归项目，其落户浏阳既源于创始人的家乡情结，也得益于当地良好的营商环境。2022年签约投产，2024年中南总部项目建成，2023年浏阳生产基地产值4.92亿元、创税超3000万元，目前公司考虑扩建增产，当地政府将全力支持。

As a project of Hunan-born entrepreneurs returning home, its settlement in Liuyang is not only due to the founder's hometown complex but also benefits from the local favorable business environment. It signed the contract and started production in 2022, and the Central South Headquarters project was completed in 2024. In 2023, the Liuyang production base had an output value of 492 million yuan and paid more than 30 million yuan in taxes. Currently, the company is considering expansion and production increase, and the local government will fully support it.